274 related articles for article (PubMed ID: 23845716)
1. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.
Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ
Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716
[TBL] [Abstract][Full Text] [Related]
2. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
6. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
[TBL] [Abstract][Full Text] [Related]
7. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
Veronesi G; Travaini LL; Maisonneuve P; Rampinelli C; Bertolotti R; Spaggiari L; Bellomi M; Paganelli G
Eur Respir J; 2015 Feb; 45(2):501-10. PubMed ID: 25261326
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.
de Hoop B; van Ginneken B; Gietema H; Prokop M
Radiology; 2012 Nov; 265(2):611-6. PubMed ID: 22929331
[TBL] [Abstract][Full Text] [Related]
11. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
Xu DM; van der Zaag-Loonen HJ; Oudkerk M; Wang Y; Vliegenthart R; Scholten ET; Verschakelen J; Prokop M; de Koning HJ; van Klaveren RJ
Radiology; 2009 Jan; 250(1):264-72. PubMed ID: 18984780
[TBL] [Abstract][Full Text] [Related]
12. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.
Walter JE; Heuvelmans MA; Yousaf-Khan U; Dorrius MD; Thunnissen E; Schermann A; Groen HJM; van der Aalst CM; Nackaerts K; Vliegenthart R; de Koning HJ; Oudkerk M
J Thorac Oncol; 2018 Sep; 13(9):1410-1414. PubMed ID: 29775805
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
14. Management of lung nodules detected by volume CT scanning.
van Klaveren RJ; Oudkerk M; Prokop M; Scholten ET; Nackaerts K; Vernhout R; van Iersel CA; van den Bergh KA; van 't Westeinde S; van der Aalst C; Thunnissen E; Xu DM; Wang Y; Zhao Y; Gietema HA; de Hoop BJ; Groen HJ; de Bock GH; van Ooijen P; Weenink C; Verschakelen J; Lammers JW; Timens W; Willebrand D; Vink A; Mali W; de Koning HJ
N Engl J Med; 2009 Dec; 361(23):2221-9. PubMed ID: 19955524
[TBL] [Abstract][Full Text] [Related]
15. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
van den Bergh KA; Essink-Bot ML; Borsboom GJ; Scholten ET; van Klaveren RJ; de Koning HJ
Eur Respir J; 2011 Jul; 38(1):154-61. PubMed ID: 21148229
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
18. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
Pinsky PF; Bellinger CR; Miller DP
J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification based on screening history: the NELSON lung cancer screening study.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223
[TBL] [Abstract][Full Text] [Related]
20. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules.
Henschke CI; Yankelevitz DF; Mirtcheva R; McGuinness G; McCauley D; Miettinen OS;
AJR Am J Roentgenol; 2002 May; 178(5):1053-7. PubMed ID: 11959700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
